REPORT FROM THE 133rd AMERICAN NEUROLOGICAL ASSOCIATION MEETING – Anticholinergic agents (e.g. tolterodine, oxybutynin) are frequently prescribed in the elderly but may produce an accelerated cognitive decline, according to a U.S. study (Janos et al. Abstract T-35).
Read More
Neurology
Earlier onset of AD in diabetes patients
December 10, 2008REPORT FROM THE 133rd AMERICAN NEUROLOGICAL ASSOCIATION MEETING – Diabetes has been linked to cognitive decline arising from vascular damage and multi-infarct dementia, but new data suggest that diabetes may also contribute to the pathogenesis of Alzheimers disease.
MoCA useful to assess cognitive function in Parkinsons disease
December 10, 2008
Leave a reply
REPORT FROM THE 133rd AMERICAN NEUROLOGICAL ASSOCIATION MEETING – The Montreal Cognitive Assessment (MoCA) appears to be more sensitive than the Mini Mental State Examination (MMSE) in detecting cognitive changes and may be useful in patients with Parkinsons disease.
Preliminary data for MS vaccines in development
November 25, 2008REPORT FROM THE WORLD CONGRESS ON TREATMENT AND RESEARCH IN MS – A number of different vaccine formulations are currently in development for MS.
Read More
Low vitamin D implicated in MS
November 25, 2008REPORT FROM THE WORLD CONGRESS ON TREATMENT AND RESEARCH IN MS – Vitamin D levels are frequently low in children and may be a risk factor for multiple sclerosis, according to two studies presented at the World Congress.